Zymergen Inc. Common Stock
ZY was delisted on the 18th of October, 2022.
91 hedge funds and large institutions have $450M invested in Zymergen Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 13 closing their positions.
267% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 9
162% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 13
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
28% more funds holding
Funds holding: 71 → 91 (+20)
22% less call options, than puts
Call options by funds: $1.76M | Put options by funds: $2.25M
32% less capital invested
Capital invested by funds: $661M → $450M (-$212M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$28.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.9M |
| 3 |
Millennium Management
New York
|
+$7.44M |
| 4 |
Morgan Stanley
New York
|
+$7.4M |
| 5 |
D.E. Shaw & Co
New York
|
+$7.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cota Capital Management
San Francisco,
California
|
-$13M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$5.15M |
| 3 |
ACG
Anchorage Capital Group
New York
|
-$3.91M |
| 4 |
BG
Bollard Group
Boston,
Massachusetts
|
-$3.64M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$2.11M |
ZY Hedge Fund Activity: Q4 2021 in Review
91 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Zymergen Inc. Common Stock (ZY) for Q4 2021, worth a combined $450M — down 32% from $661M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new ZY positions and 13 closed out — a net gain of 21 holders — while 33 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $28.6M. The largest seller was Cota Capital Management, exiting entirely with an estimated $13M sold.
- 91 institutional investors held Zymergen Inc. Common Stock (ZY) as of Q4 2021, up from 71 in Q3 2021.
- Funds reported $450M of Zymergen Inc. Common Stock stock for Q4 2021, down 32% quarter-over-quarter.
- 34 funds opened new Zymergen Inc. Common Stock positions in Q4 2021 and 13 closed out, a net change of +21 holders.
- The largest Zymergen Inc. Common Stock buyer in Q4 2021 was BlackRock, an estimated $28.6M added.
- The largest Zymergen Inc. Common Stock seller in Q4 2021 was Cota Capital Management, an estimated $13M sold.
Based on aggregated 13F filings for Q4 2021.